Daniels Corporate Advisory Company, Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315222028532 Filed on October 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.07K $294.7K
YoY Change -83.35% 17.88%
Cash & Equivalents $49.07K $294.7K
Short-Term Investments
Other Short-Term Assets $0.00 $6.250K
YoY Change -100.0% -87.3%
Inventory $104.2K $242.9K
Prepaid Expenses
Receivables $8.270K $34.78K
Other Receivables $0.00 $0.00
Total Short-Term Assets $161.5K $578.7K
YoY Change -72.09% 15.35%
LONG-TERM ASSETS
Property, Plant & Equipment $502.0K $804.0K
YoY Change -37.57% 160.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $502.0K $804.0K
YoY Change -37.57% 160.07%
TOTAL ASSETS
Total Short-Term Assets $161.5K $578.7K
Total Long-Term Assets $502.0K $804.0K
Total Assets $663.5K $1.383M
YoY Change -52.01% 70.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.605M $1.368M
YoY Change 17.33% 25.28%
Accrued Expenses $6.250K
YoY Change -83.28%
Deferred Revenue
YoY Change
Short-Term Debt $1.596M $1.593M
YoY Change 0.18% 12.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.414M $4.175M
YoY Change 5.72% -16.36%
LONG-TERM LIABILITIES
Long-Term Debt $250.4K $336.2K
YoY Change -25.51%
Other Long-Term Liabilities $250.4K
YoY Change
Total Long-Term Liabilities $250.4K $336.2K
YoY Change -25.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.414M $4.175M
Total Long-Term Liabilities $250.4K $336.2K
Total Liabilities $4.665M $4.512M
YoY Change 3.4% -9.63%
SHAREHOLDERS EQUITY
Retained Earnings -$14.01M
YoY Change
Common Stock $1.741M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.004M -$3.129M
YoY Change
Total Liabilities & Shareholders Equity $663.5K $1.383M
YoY Change -52.01% 70.52%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001498291
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
usd
CY2021Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 DCAC Stock Issued During Period Value Accrued Dividends And Accretion Of Conversion Feature On Series B Preferred Stock
StockIssuedDuringPeriodValueAccruedDividendsAndAccretionOfConversionFeatureOnSeriesBPreferredStock
usd
CY2021Q3 DCAC Stock Issued During Period Value Of Preferred Stock In Connection With Sales Made Under Private Or Public Offerings
StockIssuedDuringPeriodValueOfPreferredStockInConnectionWithSalesMadeUnderPrivateOrPublicOfferings
usd
DCAC Stock Issued During Period Value Accrued Dividends And Accretion Of Conversion Feature On Series B Preferred Stock
StockIssuedDuringPeriodValueAccruedDividendsAndAccretionOfConversionFeatureOnSeriesBPreferredStock
usd
DCAC Stock Issued During Period Value Of Preferred Stock In Connection With Sales Made Under Private Or Public Offerings
StockIssuedDuringPeriodValueOfPreferredStockInConnectionWithSalesMadeUnderPrivateOrPublicOfferings
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
DCAC Interest Penalties
InterestPenalties
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
DCAC Note Conversion Fees
NoteConversionFees
usd
DCAC Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
usd
us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
DCAC Relief Of Derivative Liability From Conversion Of Convertible Notes Into Common Stock
ReliefOfDerivativeLiabilityFromConversionOfConvertibleNotesIntoCommonStock
usd
us-gaap Stock Issued1
StockIssued1
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54762
dei Entity Registrant Name
EntityRegistrantName
DANIELS CORPORATE ADVISORY COMPANY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3667624
dei Entity Address Address Line1
EntityAddressAddressLine1
Parker Towers, 104-60
dei Entity Address Address Line2
EntityAddressAddressLine2
Queens Boulevard
dei Entity Address Address Line3
EntityAddressAddressLine3
12th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Forest Hills
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11375
dei City Area Code
CityAreaCode
(347)
dei Local Phone Number
LocalPhoneNumber
242-3148
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1741199100 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49071 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181088 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8270 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7896 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
104186 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
208504 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6096 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
161527 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
403584 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
501958 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
701006 usd
CY2022Q3 us-gaap Assets
Assets
663485 usd
CY2021Q4 us-gaap Assets
Assets
1104590 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
756286 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
710333 usd
CY2022Q3 DCAC Accounts Payable And Accrued Liabilities Related Party
AccountsPayableAndAccruedLiabilitiesRelatedParty
848784 usd
CY2021Q4 DCAC Accounts Payable And Accrued Liabilities Related Party
AccountsPayableAndAccruedLiabilitiesRelatedParty
726233 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
685000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
685000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
910679 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
801986 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1127015 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
875487 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
86635 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
168081 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4414399 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3967120 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
250410 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
338081 usd
CY2022Q3 us-gaap Liabilities
Liabilities
4664809 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4305201 usd
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
2882 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
101972 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1741199100 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1741199100 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
779298529 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
779298529 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1741199 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
779299 usd
CY2022Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
75050 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8408392 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8366837 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14014498 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12384470 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64349 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64349 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4004206 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3302583 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
663485 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1104590 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
335366 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1189371 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1328599 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3544792 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
205161 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
828142 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
812859 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2486524 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
130205 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
361229 usd
us-gaap Gross Profit
GrossProfit
515740 usd
us-gaap Gross Profit
GrossProfit
1058268 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
312636 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
287521 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
956179 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
951728 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
38126 usd
CY2021Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
11212 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
68227 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
23509 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-144305 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
84920 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-372212 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
130049 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4241 usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
334197 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-689004 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
758504 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-153393 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-183077 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-561672 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-541341 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-149152 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
151120 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1250676 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
217163 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-293457 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
236040 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1622888 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
347212 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-293457 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
236040 usd
us-gaap Net Income Loss
NetIncomeLoss
-1622888 usd
us-gaap Net Income Loss
NetIncomeLoss
347212 usd
CY2022Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1190 usd
CY2021Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
138938 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7140 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
348221 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-294647 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
97102 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1630028 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1009 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1607694371 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
510664460 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1377182003 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
377679186 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4582701804 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1088374678 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4352189436 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
377679186 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3753385 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-293457 usd
CY2022Q3 DCAC Stock Issued During Period Value Of Preferred Stock In Connection With Sales Made Under Private Or Public Offerings
StockIssuedDuringPeriodValueOfPreferredStockInConnectionWithSalesMadeUnderPrivateOrPublicOfferings
-75050 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
46375 usd
CY2022Q3 DCAC Adjustments To Additional Paid In Capital In Relief Of Derivative Liability From Conversion Of Preferred Stock Into Common Stock
AdjustmentsToAdditionalPaidInCapitalInReliefOfDerivativeLiabilityFromConversionOfPreferredStockIntoCommonStock
72501 usd
CY2022Q3 DCAC Deemed Dividends Related To Conversion Feature Of Series B Preferred Stock
DeemedDividendsRelatedToConversionFeatureOfSeriesBPreferredStock
-1190 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4004206 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-3508266 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
236040 usd
CY2021Q3 DCAC Stock Issued During Period Value Accrued Dividends And Accretion Of Conversion Feature On Series B Preferred Stock
StockIssuedDuringPeriodValueAccruedDividendsAndAccretionOfConversionFeatureOnSeriesBPreferredStock
-102839 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
46110 usd
CY2021Q3 DCAC Adjustments To Additional Paid In Capital In Relief Of Derivative Liability From Conversion Of Preferred Stock Into Common Stock
AdjustmentsToAdditionalPaidInCapitalInReliefOfDerivativeLiabilityFromConversionOfPreferredStockIntoCommonStock
12780 usd
CY2021Q3 DCAC Deemed Dividends Related To Conversion Feature Of Series B Preferred Stock
DeemedDividendsRelatedToConversionFeatureOfSeriesBPreferredStock
-13575 usd
CY2021Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-22524 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
11099 usd
CY2021Q3 DCAC Conversion Of Convertible Notes And Accrued Interest Into Common Stock
ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock
137281 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-3203894 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3302583 usd
us-gaap Net Income Loss
NetIncomeLoss
-1622888 usd
DCAC Stock Issued During Period Value Of Preferred Stock In Connection With Sales Made Under Private Or Public Offerings
StockIssuedDuringPeriodValueOfPreferredStockInConnectionWithSalesMadeUnderPrivateOrPublicOfferings
-75050 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300775 usd
DCAC Adjustments To Additional Paid In Capital In Relief Of Derivative Liability From Conversion Of Preferred Stock Into Common Stock
AdjustmentsToAdditionalPaidInCapitalInReliefOfDerivativeLiabilityFromConversionOfPreferredStockIntoCommonStock
443906 usd
DCAC Deemed Dividends Related To Conversion Feature Of Series B Preferred Stock
DeemedDividendsRelatedToConversionFeatureOfSeriesBPreferredStock
-7140 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57860 usd
DCAC Conversion Of Convertible Notes And Accrued Interest Into Common Stock
ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock
44794 usd
DCAC Relief Of Derivative Liability From Conversion Of Convertible Notes And Accrued Interest Into Common Stock
ReliefOfDerivativeLiabilityFromConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock
156120 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4004206 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3884539 usd
us-gaap Net Income Loss
NetIncomeLoss
347212 usd
DCAC Stock Issued During Period Value Accrued Dividends And Accretion Of Conversion Feature On Series B Preferred Stock
StockIssuedDuringPeriodValueAccruedDividendsAndAccretionOfConversionFeatureOnSeriesBPreferredStock
-257400 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
179246 usd
DCAC Adjustments To Additional Paid In Capital In Relief Of Derivative Liability From Conversion Of Preferred Stock Into Common Stock
AdjustmentsToAdditionalPaidInCapitalInReliefOfDerivativeLiabilityFromConversionOfPreferredStockIntoCommonStock
178429 usd
DCAC Deemed Dividends Related To Conversion Feature Of Series B Preferred Stock
DeemedDividendsRelatedToConversionFeatureOfSeriesBPreferredStock
-68297 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-22524 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60348 usd
DCAC Conversion Of Convertible Notes And Accrued Interest Into Common Stock
ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock
263631 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-3203894 usd
us-gaap Net Income Loss
NetIncomeLoss
-1622888 usd
us-gaap Net Income Loss
NetIncomeLoss
347212 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
74567 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
114530 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
117022 usd
DCAC Interest Penalties
InterestPenalties
56017 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
194545 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
57860 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
60348 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-689004 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
758504 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
68227 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
23509 usd
DCAC Note Conversion Fees
NoteConversionFees
1500 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
74941 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31876 usd
DCAC Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
122551 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-104318 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38202 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6096 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-86000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
98280 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
196052 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-81446 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-112138 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
160413 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-328235 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2818 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
152745 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
238498 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
152745 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-238498 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-87671 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
87500 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
251290 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
284500 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
316649 usd
us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
22524 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
240856 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
215860 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43473 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
329555 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-132017 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93875 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
181088 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
200858 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49071 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
294733 usd
us-gaap Interest Paid Net
InterestPaidNet
101466 usd
DCAC Conversion Of Convertible Debt And Accrued Interest Into Common Stock
ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock
44795 usd
DCAC Conversion Of Convertible Debt And Accrued Interest Into Common Stock
ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock
263361 usd
DCAC Conversion Of Preferred Stock Into Common Stock
ConversionOfPreferredStockIntoCommonStock
300775 usd
DCAC Conversion Of Preferred Stock Into Common Stock
ConversionOfPreferredStockIntoCommonStock
179246 usd
DCAC Accrued Dividends And Accretion Of Conversion Feature On Preferred Stock
AccruedDividendsAndAccretionOfConversionFeatureOnPreferredStock
111124 usd
DCAC Accrued Dividends And Accretion Of Conversion Feature On Preferred Stock
AccruedDividendsAndAccretionOfConversionFeatureOnPreferredStock
257400 usd
DCAC Deemed Dividends Related To Conversion Feature Of Preferred Stock
DeemedDividendsRelatedToConversionFeatureOfPreferredStock
7140 usd
DCAC Deemed Dividends Related To Conversion Feature Of Preferred Stock
DeemedDividendsRelatedToConversionFeatureOfPreferredStock
68296 usd
DCAC Relief Of Derivative Liability From Conversion Of Preferred Stock Into Common Stock
ReliefOfDerivativeLiabilityFromConversionOfPreferredStockIntoCommonStock
443906 usd
DCAC Relief Of Derivative Liability From Conversion Of Preferred Stock Into Common Stock
ReliefOfDerivativeLiabilityFromConversionOfPreferredStockIntoCommonStock
178249 usd
DCAC Relief Of Derivative Liability From Conversion Of Convertible Notes Into Common Stock
ReliefOfDerivativeLiabilityFromConversionOfConvertibleNotesIntoCommonStock
156120 usd
us-gaap Stock Issued1
StockIssued1
75050 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-329150 usd
CY2021Q4 DCAC Working Capital Deficit
WorkingCapitalDeficit
3563536 usd
CY2022Q3 DCAC Outstanding Indebtedness
OutstandingIndebtedness
910679 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49071 usd
CY2021Q4 DCAC Outstanding Indebtedness
OutstandingIndebtedness
801986 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2002-05-02
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zDAKMQBA4WWe" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><i><span style="text-decoration: underline"><span id="xdx_861_zIRpaEKPte5c">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_ziBmfINDvZad" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zwfeDo2pBcth">Risk and Uncertainties</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0">The Company’s future results of operations and financial condition will be impacted by the following factors, among others: its lack of capital resources, dependence on third-party management to operate the companies in which it invests and dependence on the successful development and marketing of any new products in new and existing markets. Generally, the Company is unable to predict the future status of these areas of risk and uncertainty. However, negative trends or conditions in these areas could have an adverse effect on its business.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"> </p>
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181088 usd
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
53214 usd
CY2022Q3 us-gaap Participating Mortgage Loans Unamortized Debt Discount Amount
ParticipatingMortgageLoansUnamortizedDebtDiscountAmount
74567 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
117022 usd
CY2022Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
8270 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
7896 usd
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
21648 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
21648 usd
CY2022Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1127015 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
875487 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2975007433 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1630028 usd
CY2022Q3 DCAC Working Capital Deficit
WorkingCapitalDeficit
4252872 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
887383 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
134913 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
752470 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
186377 usd
us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
50395 usd
DCAC Accumulated Depreciation Depletion And Amortization Addition
AccumulatedDepreciationDepletionAndAmortizationAddition
114530 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
250512 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
501958 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
114530 usd
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1127015 usd
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
875487 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
875487 usd
DCAC Addition Of New Derivative Liabilities From Issuance Of Series B Preferred Stock
AdditionOfNewDerivativeLiabilitiesFromIssuanceOfSeriesBPreferredStock
272586 usd
DCAC Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Relief From Conversion
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReliefFromConversion
-156120 usd
DCAC Relief Of Derivative Liabilities From Conversion Of Series B Preferred Stock
ReliefOfDerivativeLiabilitiesFromConversionOfSeriesBPreferredStock
-443906 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
578968 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1127015 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1100000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1100000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
164608 usd
DCAC Accretion Of Discounts
AccretionOfDiscounts
194545 usd
us-gaap Dividends
Dividends
7140 usd
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
140500 shares
CY2022Q3 DCAC Unamortized Discount
UnamortizedDiscount
137927 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1741199100 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1741199100 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
779298529 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
779298529 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1328599 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3544792 usd
DCAC Revenue From Contract With Customer Termination Description
RevenueFromContractWithCustomerTerminationDescription
The arrangements require weekly payments, and the customer may cancel the agreement at any time by notifying the Company in writing at least 30 days before such termination
DCAC Miscellaneous Income
MiscellaneousIncome
10913 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
87250 shares

Files In Submission

Name View Source Status
0001493152-22-028532-index-headers.html Edgar Link pending
0001493152-22-028532-index.html Edgar Link pending
0001493152-22-028532.txt Edgar Link pending
0001493152-22-028532-xbrl.zip Edgar Link pending
dcac-20220831.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
dcac-20220831_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dcac-20220831_lab.xml Edgar Link unprocessable
dcac-20220831_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dcac-20220831_def.xml Edgar Link unprocessable